F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia Federal regulators will no longer require patients to provide blood [...] By digitalstudios|2025-02-26T02:32:35+00:00February 26, 2025|3rd Party Pharmaceutical Industry News|Comments Off on F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia Read More